Lijuan Song | Cellular Neuroscience | Best Researcher Award

Published on by Neuroscientists

Prof. Lijuan Song | Cellular Neuroscience | Best Researcher Award

Prof. Lijuan Song,  Shanxi University of Chinese Medicine, China.

Throughout my career, I have passionately committed myself to integrating traditional Chinese medicine and Western medicine to advance the prevention and treatment of brain diseases, particularly ischemic cerebrovascular diseases and neurodegenerative disorders. By leading 14 national and provincial-level research projects, publishing over 130 academic papers, and contributing significantly to educational reform, I have built a strong foundation of scientific innovation and clinical excellence. With achievements recognized both nationally and internationally, and a consistent focus on combining research, teaching, and clinical work, I have significantly impacted the fields of neuroprotection and integrative medicine.

Profile

Scopus

 

🎓 Early Academic Pursuits

From the outset of my academic journey, I committed myself to the profound study of both traditional Chinese medicine and Western medicine, aspiring to bridge these two disciplines for the betterment of brain disease treatment. I pursued a rigorous path of education and research, laying a strong foundation that later allowed me to integrate diverse medical perspectives. Early in my career, I developed a particular interest in ischemic cerebrovascular diseases and neurodegenerative conditions, setting the stage for my lifelong mission to innovate in these critical areas.

🩺 Professional Endeavors

My professional career has been a dynamic blend of teaching, clinical practice, and scientific research, with a special focus on the prevention and treatment of brain diseases. I have successfully presided over 14 prestigious national and provincial-level projects, including those funded by the National Natural Science Foundation of China and the China Postdoctoral Science Foundation. Through my work, I have consistently emphasized the value of integrating traditional Chinese medicine with modern Western practices, ensuring that my clinical and research contributions are both culturally rooted and globally relevant.

🔬 Contributions and Research Focus

Throughout my research journey, I have concentrated on ischemic cerebrovascular diseases and neurodegenerative diseases, pioneering integrated approaches for their prevention and treatment. I have published 133 scientific papers, including 45 in SCI-indexed journals, with nearly 700 citations and an H-index of 15. One of my papers published in Neural Regeneration Research (NRR) has been recognized in the ESI highest citation list, achieving an impressive 97 citations. Beyond scientific research, I have also contributed significantly to educational innovation, authoring educational reform articles in the China Journal of Traditional Chinese Medicine and editing influential academic books.

🏆 Accolades and Recognition

My dedication to scientific advancement and education has earned me multiple prestigious honors. As the first author, I received the First Prize of the Academic Achievement Award from the China Association for the Promotion of Traditional Chinese Medicine Research. I have secured three authorized patents and two software copyrights, further showcasing my commitment to innovation. Additionally, my work has been featured through oral presentations at internationally renowned academic forums such as the Autoimmunity Congress and the World Stroke Congress, and recognized by respected platforms like Logic Neuroscience and Neuroweekly.

🌍 Impact and Influence

My influence extends beyond academia into public science education and medical philosophy dialogues. I have been repeatedly invited to deliver popular science talks and academic lectures at events like the Medical Philosophy Expert Meeting Room. My presentation at the 2022 International Neural Regeneration Summit Forum earned the Most Popular Award, affirming my ability to translate complex research into impactful and accessible knowledge for diverse audiences.

📚 Legacy in Education and Publishing

In addition to research and clinical achievements, I have made significant contributions to academic publishing and educational reform. My independently authored book, Progress in Integrated Traditional Chinese and Western Medicine Prevention and Treatment of Ischemic Cerebrovascular Disease, was published by People’s Health Publishing House. I have served as the first editor-in-chief for three important books, including Exploration of Teaching Models in Higher Education Pharmaceutical Education, which was honored by its selection into the “Library of Young Scholars in Universities,” marking a lasting contribution to the future of pharmaceutical education.

🚀 Future Contributions and Aspirations

Looking ahead, I aspire to further deepen the integration of traditional Chinese and Western medicine, particularly in brain disease prevention and therapy. I am committed to leading new research directions, fostering international collaborations, and nurturing a new generation of scholars who value the richness of cross-cultural medical practices. My future endeavors will continue to reflect a relentless pursuit of scientific excellence, compassionate clinical practice, and transformative education for the global health community.

Publication

  • Title: Effect of tetramethylpyrazine on neuroinflammation after cerebral ischemia and hypoxia based on mannose-binding lectin
    Authors: Y. Duan, Yanzhe; J. Hua, Jianlin; Y. Yan, Yuqing; L. Song, Lijuan
    Year: 2025

 

  • Title: Polysaccharides from Ganoderma lucidum attenuate cognitive impairment in 5xFAD mice by inhibiting oxidative stress and modulating mitochondrial dynamics via the Nrf2/antioxidative axis activation
    Authors: J. Yu, Jiezhong; C. Ma, Cungen
    Year: 2025

 

  • Title: Hydroxysafflower yellow A alleviates the inflammatory response in astrocytes following cerebral ischemia by inhibiting the LCN2/STAT3 feedback loop
    Authors: L. Song, Lijuan; Y. Wu, Yige; L. Yin, Lijun; B. Xiao, Baoguo; C. Ma, Cungen
    Year: 2025

 

  • Title: Mechanism of senegenin in improving lipopolysacchride-induced inflammatory response of BV2 microglial cell
    Authors: B. Mu, Bingtao; M. Guo, Minfang; J. Yu, Jingwen; J. Yu, Jiezhong; L. Song, Lijuan
    Year: 2025

 

  • Title: Effectiveness and Safety of Blending Traditional Chinese Medicine With Western Medicine for Enhanced Secondary Stroke Prevention: A Meta-analysis of RCTs
    Authors: C. Wen, Chunli; L. Song, Lijuan; C. Ma, Cungen; F. Hu, Fengyun; L. Zhu, Linggqun
    Year: 2025

 

 

🎯 Conclusion

Driven by a deep belief in the power of integration between ancient wisdom and modern science, I have continuously sought to pioneer new frontiers in brain disease treatment. My work has not only advanced research but also nurtured future generations through educational contributions and public science communication. Moving forward, I remain committed to expanding the reach and depth of integrated medicine, aiming to create a lasting legacy of innovation, healing, and academic excellence for global healthcare advancement.

Peng Jun | Cellular Neuroscience | Best Researcher Award

Published on by Neuroscientists

Prof. Peng Jun | Cellular Neuroscience | Best Researcher Award

Prof. Peng Jun, Qilu hospital of Shandong University, China.

Professor Jun Peng is a distinguished leader in hematology, currently serving as Vice President of Qilu Hospital of Shandong University and Director of the Department of Hematology. His research is deeply rooted in the immunological pathogenesis and immune tolerance of primary immune thrombocytopenia (ITP), where he has made significant breakthroughs, including the publication of 14 papers in Blood. With a career supported by prestigious national awards, and leadership in 15 high-level research projects, Professor Peng is also a vital figure in Chinese hematology societies and editorial boards of leading journals. His academic rigor, clinical insight, and mentorship continue to shape the future of hematological science in China and beyond.

Profile

Scopus

🎓 Early Academic Pursuits

Professor Jun Peng embarked on his academic journey with a strong commitment to medicine and hematological sciences. From the outset, he exhibited exceptional academic talent and dedication, leading him to pursue both an M.D. and Ph.D. His early education laid a robust foundation for his future specialization in hematology, particularly in the complex field of immunological disorders. His doctoral work, recognized nationally, foreshadowed the groundbreaking contributions he would later make in immune thrombocytopenia research.

🩺 Professional Endeavors

Currently serving as the Vice President of Qilu Hospital of Shandong University, Professor Peng also holds the roles of Chief Physician, Professor, and Ph.D./M.D. Advisor, in addition to being the Director of the Department of Hematology. His clinical and academic responsibilities are carried out with unwavering diligence, mentoring future medical experts while overseeing high-level clinical operations. As a Distinguished Professor of Shandong University, he is actively engaged in shaping the university’s medical excellence on both national and global stages.

🔬 Contributions and Research Focus

At the heart of Professor Peng’s career is his pioneering work on the immunological pathogenesis and immune tolerance of primary immune thrombocytopenia (ITP). He has made substantial contributions to understanding the autoimmune mechanisms that underlie ITP, one of the most challenging hematologic disorders. His scholarly dedication is evidenced by the publication of 14 papers in Blood, a leading journal in hematology, where he served as corresponding or co-corresponding author. His research, grounded in clinical insight and scientific precision, has contributed new perspectives on immune regulation in hematologic diseases.

🏆 Accolades and Recognition

Professor Peng’s excellence has been recognized with numerous prestigious awards. These include the National Science Fund for Distinguished Young Scholars, which highlights his scientific creativity and impact at a young age. He is also a recipient of the One-Hundred National Outstanding Doctoral Dissertation Award, a testament to the academic rigor of his early research. Additionally, he earned the First Prize of the Natural Science Award for Outstanding Achievements in Scientific Research from the Ministry of Education and the Science and Technology Progress Award, reflecting both his academic brilliance and practical impact in the medical field.

🧪 Impact and Influence

Beyond research publications, Professor Peng has significantly influenced the broader scientific and medical communities. As a principal investigator, he has led fifteen national and ministerial-level research projects, including those funded by the National Natural Science Foundation of China and the 973 Program under the Ministry of Science and Technology. His leadership extends to active roles in national academic societies, including the Thrombosis and Hemostasis Group of the Chinese Society of Hematology and the Professional Committee of Experimental Hematology of the Chinese Society of Pathophysiology. These positions allow him to shape the direction of hematological research and clinical guidelines in China.

📚 Academic Leadership and Editorial Roles

A passionate advocate for knowledge dissemination, Professor Peng is a key editorial board member for several respected journals such as Thrombosis Journal, Thrombosis Research, Journal of Clinical Hematology, and the Chinese Journal of Hematology. Through these roles, he ensures that cutting-edge research in hematology is critically evaluated and shared widely, fostering a culture of scientific excellence and collaboration across the globe.

🌟 Legacy and Future Contributions

Professor Jun Peng’s legacy is being forged not only through his past achievements but also through his continued commitment to the advancement of hematological science. His influence spans clinical innovation, academic mentorship, and scientific discovery. As he continues to push the boundaries of understanding in ITP and immune tolerance, he inspires a new generation of physician-scientists. The impact of his work promises to resonate for years to come, offering hope and healing for patients and propelling China’s medical research onto the world stage.

Publication

  • Title: Autoimmune effector mechanisms associated with a defective immunosuppressive axis in immune thrombocytopenia (ITP)
    Authors: Qizhao Li, Geneviève Marcoux, Yuefen Hu, Jung Peng, John W. Semple
    Year: 2024

 

  • Title: Quantitative detection of macular microvascular abnormalities identified by optical coherence tomography angiography in different hematological diseases
    Authors: Tianzi Jian, Fabao Xu, Guihua Li, Li Zhang, Jung Peng
    Year: 2024

 

  • Title: Nicotinamide enhances Treg differentiation by promoting Foxp3 acetylation in immune thrombocytopenia
    Authors: Ju Li, Cheng Zhang, Yuefen Hu, Qi Feng, Xiang Hu
    Year: 2024

 

  • Title: The effects of complement-independent, autoantibody-induced apoptosis of platelets in immune thrombocytopenia (ITP)
    Authors: Lin Sun, Yichen Zhang, Ping Chen, Jung Peng, Zi Sheng
    Year: 2024

 

  • Title: Post-transplant lymphoproliferative disorders after allogeneic hematopoietic stem cell transplantation: a case report, meta-analysis, and systematic review
    Authors: You Yuan Su, Yafei Yu, Zhenyu Yan, Jung Peng, Xinguang Liu
    Year: 2024

 

  • Title: Ion channel Piezo1 activation aggravates the endothelial dysfunction under a high glucose environment
    Authors: Xiaoyu Zhang, Shaoqiu Leng, Xinyue Liu, Shuwen Wang, Jung Peng
    Year: 2024

 

  • Title: Intelligent dual-modality label-free cell classification with light scattering imaging and Raman spectra measurements
    Authors: Faihaa Mohammed Eltigani, Xiaoyu Zhang, Min Liu, Jung Peng, Xuantao Su
    Year: 2024

 

  • Title: Eltrombopag plus diacerein vs eltrombopag in patients with ITP: a multicenter, randomized, open-label phase 2 trial
    Authors: Lu Sun, Xiaoyang Huang, Juan Wang, Ming Hou, Yu Hou
    Year: 2024

 

  • Title: Risk Factors for Mortality in Critically Ill Patients with Coagulation Abnormalities: A Retrospective Cohort Study
    Authors: Qiuyu Guo, Jung Peng, Tichao Shan, Miao Xu
    Year: 2024

 

  • Title: Platelet-derived TGF-β1 induces functional reprogramming of myeloid-derived suppressor cells in immune thrombocytopenia
    Authors: Lingjun Wang, Haoyi Wang, Mingfang Zhu, Ming Hou, Yu Hou
    Year: 2024

 

✅ Conclusion

Through his pioneering research, unwavering clinical dedication, and impactful academic leadership, Professor Jun Peng stands at the forefront of immuno-hematology. His work not only deepens scientific understanding of ITP but also contributes directly to improved patient outcomes. As he continues to inspire through teaching, research, and innovation, Professor Peng’s legacy is one of excellence, influence, and ongoing transformation in the global hematology community.

 

Wenhui He | Cellular Neuroscience | Innovative Research Award

Published on by Neuroscientists

Mr. Wenhui He | Cellular Neuroscience | Innovative Research Award

Mr. Wenhui He, Army Medical University, China.

Wenhui He is a dedicated lecturer and researcher at the Army Medical University, where she has spent eight years teaching biochemistry and molecular biology. With a strong academic background and deep expertise in neural regulation and cardiovascular diseases, her research delves into complex mechanisms underlying aortic dissection and atherosclerosis. Through her dual roles in education and scientific discovery, she contributes significantly to both student development and the broader medical research community. Her work not only adds to the scientific understanding of cardiovascular pathophysiology but also informs potential therapeutic strategies.

Profile

Scopus

 

🎓 Early Academic Pursuits

Wenhui He embarked on her academic journey with a deep passion for unraveling the complexities of human biology, particularly focusing on the intricate workings of the cardiovascular system. Her early education laid a strong foundation in biochemistry and molecular biology, disciplines that would later become central to her teaching and research. With a commitment to excellence, she pursued advanced studies that equipped her with the scientific rigor and analytical skills necessary for impactful research in biomedical sciences.

🧪 Professional Endeavors

Currently serving as a lecturer at the School of Basic Medical Sciences, Army Medical University, Wenhui He has spent the past eight years educating future medical professionals. She specializes in biochemistry and molecular biology, delivering foundational knowledge with clarity and depth. Her role extends beyond teaching, as she actively contributes to the academic and research community within the university, balancing the dual responsibilities of pedagogy and scientific exploration.

🧬 Contributions and Research Focus

Wenhui He’s research is centered on the neural regulation and molecular mechanisms of cardiovascular diseases, particularly aortic dissection and atherosclerosis. Her work investigates the underlying signaling pathways and neurovascular interactions that drive the onset and progression of these conditions. By integrating neurobiology with vascular pathology, her studies aim to uncover therapeutic targets and improve understanding of disease mechanisms, thus contributing to the development of more effective interventions.

🏅 Accolades and Recognition

Throughout her academic and professional career, Wenhui He has earned the respect of her peers and students alike. While her contributions have been largely rooted in teaching and research, her dedication to academic excellence and her commitment to medical education have not gone unnoticed. Her role as a faculty member at a leading military medical institution speaks to her capabilities and the trust placed in her by the academic community.

🌍 Impact and Influence

Through her dual engagement in teaching and research, Wenhui He has had a meaningful impact on both the scientific community and the future of medicine. Her research contributes valuable knowledge to the fields of cardiovascular science and neurovascular biology, while her teaching helps shape the minds of tomorrow’s medical practitioners. The blend of theoretical insight and practical relevance in her work makes her an influential figure in her domain.

🔬 Legacy and Future Contributions

With a strong foundation in molecular biology and a clear focus on cardiovascular disease mechanisms, Wenhui He is poised to continue contributing groundbreaking research. Her future endeavors aim to bridge the gap between basic medical science and clinical application, ensuring that her work remains both scientifically significant and socially relevant. As she mentors young scientists and expands her research horizons, her legacy is likely to grow in scope and impact.

❤️‍🩹 Commitment to Cardiovascular Health

Wenhui He’s unwavering dedication to understanding and combating cardiovascular diseases reflects her commitment to public health. Her focus on conditions like aortic dissection and atherosclerosis not only addresses some of the leading causes of mortality but also aligns with global efforts to reduce the burden of chronic illnesses. Through education, research, and collaboration, she continues to make strides in protecting and improving heart health.

Publicatio

  • Title: From inflammation to remodelling: A novel BASP1⁺ monocyte subset as a catalyst for acute aortic dissection

  • Authors: Wenhui He, Sanjiu Yu, Jun Li, Wei Cheng, Shuangshuang Dai, et al.

  • Year: 2025

 

🏁 Conclusion

Combining passion, precision, and purpose, Wenhui He exemplifies the modern medical scientist—committed to excellence in teaching and innovation in research. Her journey reflects a meaningful integration of neuroscience, molecular biology, and cardiovascular science. As she continues to push boundaries in her field, her impact will be felt not only through her discoveries but also through the many students and researchers she inspires. Her career stands as a testament to the power of scientific curiosity and educational dedication in shaping a healthier future.

 

Soumya Pahari | Clinical Neuroscience | Young Researcher Award

Published on by Neuroscientists

Dr. Soumya Pahari | Clinical Neuroscience | Young Researcher Award

Dr. Soumya Pahari,  Nepalese Army Institute of Health Sciences, Nepal.

Dr. Soumya Pahari, MBBS, is a globally engaged physician with a deep-rooted passion for neurosurgery, clinical research, and public health advocacy. From excelling in medical school on a full academic scholarship to completing hands-on neurosurgical training in both Nepal and the U.S., Dr. Pahari has built a career that blends clinical excellence with scholarly rigor. Their dedication to global neurosurgical research, reflected through projects with Vanderbilt University and Mission Brain Foundation, demonstrates a commitment to solving complex medical challenges through evidence-based innovation. Beyond the operating theater, their work as a mental health advocate and educator underscores a holistic approach to medicine that prioritizes human connection, education, and equity.

 

Profile

Google Scholar

 

🎓 Early Academic Pursuits

Dr. Soumya Pahari’s academic journey began with a strong foundation in science, nurtured during their high school years at St. Xavier’s College, Nepal,  Their passion for medicine soon led them to pursue an MBBS degree at the Nepalese Army Institute of Health Sciences (NAIHS), where they not only excelled academically but also earned the prestigious NAIHS Academic Scholarship in 2016. Throughout medical school, they developed a keen interest in neuroscience and surgical disciplines, which laid the groundwork for their future specialization in neurosurgery and global neurosurgical initiatives.

🧠 Professional Endeavors in Neurosurgery

Driven by an unrelenting commitment to clinical excellence, Dr. Pahari’s professional training includes a year-long position as House Officer in the Department of Neurosurgery at Shree Birendra Hospital, Nepal’s only neurosurgical unit under the Nepalese Army. Here, they performed critical procedures such as EVD insertion, burr hole evacuation, and tracheostomy, while actively assisting in advanced surgeries like aneurysm clipping and tumor resections. Later, as a Visiting Scholar in Neurosurgery at West Virginia University (WV, USA) under Dr. P. David Adelson, they broadened their exposure by shadowing surgeons, presenting clinical cases, and initiating a quality improvement project focused on vagal nerve stimulators for refractory epilepsy patients. These experiences have collectively enriched Dr. Pahari’s surgical acumen and global neurosurgical insight.

🔬 Contributions and Research Focus

Research forms a core pillar of Dr. Pahari’s career, with a focus on pediatric cerebrovascular disorders, endovascular interventions in extradural hematomas, and quality improvement in epilepsy care. As a Research Collaborator with Vanderbilt Global Neurosurgery Program, they are leading a systematic review to assess the global burden of pediatric cerebrovascular diseases, contributing meaningfully to evidence-based global neurosurgical strategies. Simultaneously, their work with the Mission Brain Foundation aims to analyze the emerging utility of endovascular techniques in traumatic brain injury management. Earlier, they also contributed as an administrator and content developer at the Abdulrauf University of Neurosurgery’s Research Institute in California, helping curate educational content for aspiring neurosurgeon-scientists.

🌍 Advocacy, Mental Health & Global Impact

Dr. Pahari’s commitment to health extends beyond the operating room into the domain of mental health and psychosocial well-being. As a Founding Board Member of Antardhoni Nepal, they’ve played a vital role in promoting mental health awareness and support services in underserved communities. Their leadership also reflects through media engagement as a Podcast Host for ‘Behind White Coats’, a platform where pressing global health issues and common illnesses are discussed with clarity and compassion. These endeavors underline their belief in a holistic approach to health, where mental, social, and physical well-being are equally prioritized.

🏆 Accolades and Recognition

Throughout their academic and professional career, Dr. Pahari has garnered several accolades, notably being ECFMG Certified in August 2024 and scoring an impressive 253 on USMLE Step 2. Their achievements are further supported by certifications such as the Diploma in Neurotrauma Care from the Global Neuro Foundation, which granted them 43.5 AMA PRA Category 1 credits, enhancing their preparedness for managing acute neurotrauma in global contexts. These recognitions reflect their unwavering commitment to clinical excellence and continuous learning.

📢 Influence Through Education and Media

An inspiring communicator and educator, Dr. Pahari has invested time in peer tutoring through Medlife Stories, where they guided junior students through complex medical concepts. Their innovative spirit also led them to head marketing strategies for The SET Exhibition during their early college years—an event that showcased student innovation in science and technology. Through educational content creation, public speaking, and mentoring, Dr. Pahari continues to shape the next generation of healthcare leaders while making medicine more accessible and engaging for all.

🚀 Legacy and Future Contributions

As Dr. Soumya Pahari looks ahead, their vision is clearly anchored in the intersection of clinical neurosurgery, global health equity, and academic research. With ongoing collaborations in global neurosurgical research and growing experience in both developed and developing healthcare systems, they are uniquely positioned to bridge disparities in neurosurgical care. Their future contributions are expected to amplify the voices of underrepresented populations in global health discourse, enhance neurosurgical systems through data-driven quality improvement, and inspire young physicians to approach medicine with both empathy and rigor. Their legacy, still unfolding, promises to be one of profound impact, innovation, and inclusion.

Publication

 

  • Title: Gallstone among patients presenting to the department of surgery in a tertiary care center: a descriptive cross-sectional study
    Authors: S Pahari, S Basukala, U Piya, Y Khand, B Thapa, O Thapa, S Thapa
    Year: 2023

 

  • Title: A rare case of retroperitoneal extension in Fournier’s gangrene: A case report and review of literature
    Authors: S Basukala, Y Khand, S Pahari, KB Shah, A Shah
    Year: 2022

 

  • Title: Large posterior mediastinal ganglioneuroma with intradural cervical spine extension: a rare case report and review of literature
    Authors: A Dahal, JJ Malla, D Neupane, N Lageju, LS Jaiswal, S Chaudhary, …
    Year: 2022

 

  • Title: Complicated pylephlebitis secondary to perforated appendicitis in a child-A rare case report
    Authors: S Pahari, M Shrestha, S Basukala, P Kafle, K Rai, Y Khand, O Thapa, …
    Year: 2022

 

  • Title: A life-threatening complication of biliary peritonitis following T-tube removal: A case report and review of literature
    Authors: Y Khand, S Basukala, U Piya, P Mainali, S Pahari, KB Shah
    Year: 2022

 

  • Title: Spontaneous splenic hematoma secondary to dengue infection: a rare case report
    Authors: S Pahari, S Basukala, P Kunwar, K Thapa, Y Khand, O Thapa
    Year: 2023

 

  • Title: An unusual case of perforated stump appendicitis: a case report
    Authors: S Basukala, BD Pathak, S Pahari, S Gurung, B Basukala, BB Rayamajhi, …
    Year: 2022

 

  • Title: Acute Pancreatitis among Patients Visiting the Department of Surgery in a Tertiary Care Centre: A Descriptive Cross-sectional Study
    Authors: S Basukala, BD Pathak, P Dawadi, S Bohara, A Tamang, S Pahari, …
    Year: 2023

 

  • Title: Patient Safety and organizational Safety Culture in Surgery: A Need of an Hour in the developing countries
    Authors: S Basukala, S Bohara, A Thapa, A Shah, S Pahari, Y Khand, O Thapa, …
    Year: 2022

 

  • Title: Acute recurrent pancreatitis in a child with pancreatic divisum–A case report
    Authors: O Thapa, S Basukala, M Shrestha, Y Khand, S Pahari, S Bohara, A Thapa, …
    Year: 2022

 

✅ Conclusion

With a powerful blend of academic distinction, surgical skill, and compassionate advocacy, Dr. Soumya Pahari stands at the forefront of a new generation of physician-leaders. Their journey is a testament to the impact that global collaboration, research, and empathy can have on healthcare. As they continue to pursue excellence in neurosurgery and global health, their work promises not only to improve lives in the operating room but to inspire systemic change across borders. The future undoubtedly holds even greater contributions from this rising medical changemaker.

Ketan Bulsara | Cellular Neuroscience | Excellence in Neuroscience Research Award

Published on by Neuroscientists

Dr. Ketan Bulsara | Cellular Neuroscience | Excellence in Neuroscience Research Award

Dr. Ketan Bulsara, University of Connecticut, United States.

Dr. Ketan Ramanlal Bulsara is a distinguished neurosurgeon, educator, and administrator whose career has been defined by excellence in academic leadership, innovative research, and patient-centered surgical advancements. With a strong foundation in medical education and training, he has held prestigious positions at leading institutions, making significant contributions to the fields of cerebrovascular and skull base surgery. His work in neurosurgical education, healthcare policy, and perioperative quality improvement continues to influence the next generation of medical professionals.

Profile

Google Scholar

 

🎓 Early Academic Pursuits: The Foundation of Excellence

Dr. Ketan Ramanlal Bulsara’s journey into the world of neurosurgery began with a strong academic foundation. He earned his Bachelor of Science in Biology and Neuroscience, graduating Magna Cum Laude from Davidson College in 1992. His passion for medicine led him to Duke University School of Medicine, where he earned his Medical Degree with Honors in 1996. Committed to mastering his craft, Dr. Bulsara underwent rigorous neurosurgical training at Duke University Medical Center, progressing through internship, residency, and chief residency roles. His dedication to specialized knowledge took him to the University of Iowa for a fellowship in Transoral Surgery and later to Duke’s Neurovascular Program for an advanced Endovascular Fellowship, earning CAST certification by the Senior Neurological Society.

🎉 Professional Endeavors: Pioneering Neurosurgical Excellence

Dr. Bulsara has held esteemed academic and leadership positions throughout his career. Beginning as an Assistant Professor at the University of Missouri, he quickly ascended to directorship roles at Yale University, where he led Neuroendovascular and Skull Base Surgery Programs. His expertise and leadership took him to UConn Health, where he has served as Professor and Chief of Neurosurgery since 2017. As Program Director of UConn’s Neurosurgery Residency Training Program and Director of Operating Room Quality, he has been instrumental in shaping the next generation of neurosurgeons. His administrative impact extended further when he was appointed Interim Inaugural Chairman of UConn’s Department of Neurosurgery in 2024.

📚 Contributions and Research Focus: Advancing Neurosurgical Innovation

Throughout his career, Dr. Bulsara has been at the forefront of neurosurgical research, focusing on cerebrovascular and skull base surgery, neuroendovascular techniques, and perioperative advancements. His tenure at Yale and UConn Health has been marked by groundbreaking contributions to neurosurgical methodologies, patient safety protocols, and cutting-edge surgical interventions. With a keen interest in medical policy and administration, he also serves as Chair of the UConn Health/University of Connecticut Dean’s Task Force on Coding and Documentation, ensuring optimal standards in medical practice.

🏆 Accolades and Recognition: A Trailblazer’s Achievements

Dr. Bulsara’s exemplary work has earned him widespread recognition in academic, clinical, and administrative spheres. His leadership has been pivotal in strengthening neurosurgical departments and residency programs, earning respect from peers and students alike. His continued commitment to excellence led him to pursue an Executive MBA at Yale School of Management, which he completed in 2017, equipping him with advanced skills in healthcare management and strategic planning. Furthering his multidisciplinary expertise, he embarked on a legal education at the University of Connecticut School of Law in 2024, highlighting his commitment to integrating medicine, business, and law for the betterment of healthcare.

💡 Impact and Influence: Shaping the Future of Neurosurgery

Dr. Bulsara’s influence extends far beyond the operating room. As a mentor, he has trained and guided numerous neurosurgeons, instilling in them the values of precision, innovation, and patient-centered care. His research and administrative contributions have shaped hospital policies and perioperative strategies, leading to improved surgical outcomes and enhanced healthcare delivery systems. His work in academic leadership continues to bridge the gap between medical practice, research, and education.

 

Publication

  • Spinal axon regeneration evoked by replacing two growth cone proteins in adult neurons – HM Bomze, KR Bulsara, BJ Iskandar, P Caroni, JH Pate Skene (2001)

 

  • Longitudinal molecular trajectories of diffuse glioma in adults – FP Barthel, KC Johnson, FS Varn, AD Moskalik, G Tanner, E Kocakavuk, et al. (2019)

 

  • Glioma progression is shaped by genetic evolution and microenvironment interactions – FS Varn, KC Johnson, J Martinek, JT Huse, MLP Nasrallah, P Wesseling, et al. (2022)

 

  • Accuracy of prediction instruments for diagnosing large vessel occlusion in individuals with suspected stroke: a systematic review for the 2018 guidelines for the early… – EE Smith, DM Kent, KR Bulsara, LY Leung, JH Lichtman, MJ Reeves, et al. (2018)

 

  • Perioperative complications in transforaminal lumbar interbody fusion versus anterior–posterior reconstruction for lumbar disc degeneration and instability – AT Villavicencio, S Burneikiene, KR Bulsara, JJ Thramann (2006)

 

  • Vessel wall magnetic resonance imaging identifies the site of rupture in patients with multiple intracranial aneurysms: proof of principle – CC Matouk, DM Mandell, M Günel, KR Bulsara, A Malhotra, R Hebert, et al. (2013)

 

  • Safety of transforaminal lumbar interbody fusion and intervertebral recombinant human bone morphogenetic protein—2 – AT Villavicencio, S Burneikiene, EL Nelson, KR Bulsara, M Favors, et al. (2005)

 

  • Laminectomy versus percutaneous electrode placement for spinal cord stimulation – AT Villavicencio, JC Leveque, L Rubin, K Bulsara, JP Gorecki (2000)

 

  • Indications for thrombectomy in acute ischemic stroke from emergent large vessel occlusion (ELVO): report of the SNIS Standards and Guidelines Committee – M Mokin, SA Ansari, RA McTaggart, KR Bulsara, M Goyal, M Chen, et al. (2019)

 

  • Review of the literature on de novo formation of cavernous malformations of the central nervous system after radiation therapy – SM Nimjee, CJ Powers, KR Bulsara (2006)

 

💪 Conclusion

A visionary in neurosurgery, Dr. Bulsara’s impact transcends surgical practice, reaching into medical education, research, and healthcare administration. His multidisciplinary approach—combining medicine, business, and law—positions him as a leader in shaping the future of healthcare. His commitment to innovation and excellence ensures that his contributions will continue to elevate neurosurgical standards and inspire future generations of medical professionals.

 

 

 

Rita Abi Rached | Neuropharmacology | Best Researcher Award

Published on by Neuroscientists

Dr. Rita Abi Rached | Neuropharmacology | Best Researcher Award

Dr. Rita Abi Rached, University of Cagliari, Italy.

Rita Joseph Abi Rached has built a remarkable career at the intersection of food chemistry, biochemistry, and sustainability. From her foundational academic journey to her current research in agri-food by-product valorization, she has continuously sought innovative solutions to environmental and health-related challenges. Her expertise spans industry collaborations, cutting-edge research, and impactful scientific contributions, making her a leading figure in sustainable food science.

Profile

Google Scholar

✨ Early Academic Pursuits – A Passion for Science ✨

From an early age, Rita Joseph Abi Rached demonstrated an innate curiosity for the sciences, particularly in the fields of biochemistry and food chemistry. She embarked on her academic journey with a Bachelor’s degree in Biochemistry from Saint Joseph University of Beirut in 2017, where she cultivated a strong foundation in molecular sciences. Her passion for the chemical intricacies of food systems led her to pursue a Master’s degree in Food Chemistry in 2019, further refining her expertise in the biochemical properties of agro-food products. This academic dedication ultimately culminated in a Double Ph.D. in Life, Environmental, and Pharmaceutical Sciences from the University of Cagliari and Saint Joseph University of Beirut in 2024, marking a significant milestone in her scholarly endeavors.

🌱 Professional Endeavors – Bridging Academia and Industry 🌱

With an unwavering commitment to research, Rita transitioned from academia to professional scientific exploration. Her early training included hands-on experiences at Château Ksara, where she assessed grape phenolic maturity, and at Libby’s, where she gained insights into quality control and microbiological analyses. Further strengthening her industrial expertise, she worked as a lab researcher and research assistant at Saint Joseph University, refining her skills in polyphenol analysis and microbiological assessments. These experiences not only expanded her technical competencies but also paved the way for her role as a dedicated researcher at the University of Cagliari, where she currently investigates sustainable approaches to agri-food by-product valorization.

🤝 Contributions and Research Focus – Innovating for a Sustainable Future 🤝

Rita’s research is deeply rooted in sustainability and the innovative utilization of agricultural and industrial biomasses. Her current work revolves around the valorization of agro-industrial by-products, transforming waste into functional bioactive compounds for health and agriculture. She has actively contributed to groundbreaking projects such as BESTMEDGRAPE, which applied nanotechnological strategies to enhance Mediterranean grape derivatives, and MEDLENTISK, an Erasmus+ initiative that explored best practices for mastic tree fixed oil. Additionally, she played a pivotal role in TECNOCOVID, a project leveraging natural bioactives and nanotechnologies to combat COVID-19. Her most recent endeavor, NUTRINNOVA, focuses on utilizing nutriosomes derived from agro-industrial waste to mitigate dysbiosis, oxidative stress, and cognitive decline, further establishing her as a pioneer in sustainable food research.

🏆 Accolades and Recognition – A Scholar’s Journey 🏆

Throughout her career, Rita has garnered significant recognition for her impactful contributions to scientific research. Her work has been widely cited, with a citation index of 72 and an h-index of 4, reflecting her influence in the academic community. These achievements underscore the relevance of her studies in the fields of food science, biotechnology, and environmental sustainability. Her research outputs continue to inspire new approaches to the responsible and efficient use of natural resources, positioning her as a respected voice in her domain.

🔍 Impact and Influence – Shaping the Scientific Landscape 🔍

As an advocate for innovative and sustainable research, Rita’s work has transcended the boundaries of traditional food science, merging interdisciplinary methodologies to address global challenges. By focusing on agri-food waste valorization, she has provided meaningful insights into reducing environmental impact while enhancing the nutritional and therapeutic value of food by-products. Her collaborations with industry leaders and academic institutions have reinforced her reputation as a key contributor to cutting-edge scientific advancements.

 

Publication

  • Title: Entrapment of Citrus limon var. pompia Essential Oil or Pure Citral in Liposomes Tailored as Mouthwash for the Treatment of Oral Cavity Diseases
    Author(s): L Palmas, M Aroffu, GL Petretto, E Escribano-Ferrer, O Díez-Sales, …
    Year: 2020

 

  • Title: Extraction, Characterization and Incorporation of Hypericum scruglii Extract in Ad Hoc Formulated Phospholipid Vesicles Designed for the Treatment of Skin
    Author(s): M Allaw, M Manconi, M Aroffu, F Marongiu, M Porceddu, G Bacchetta, …
    Year: 2020

 

  • Title: Optimization of Polyphenols Extraction from Purple Corn Cobs Using ß-Cyclodextrin as a Green Solvent
    Author(s): HN Rajha, S Khabbaz, R Abi Rached, E Debs, RG Maroun, N Louka
    Year: 2020

 

  • Title: From Grape By-Products to Enriched Yogurt Containing Pomace Extract Loaded in Nanotechnological Nutriosomes Tailored for Promoting Gastro-Intestinal Wellness
    Author(s): I Castangia, F Fulgheri, FJ Leyva-Jimenez, ME Alañón, ML Cádiz-Gurrea, …
    Year: 2023

 

  • Title: From Field to Waste Valorization: A Preliminary Study Exploring the Impact of the Wine Supply Chain on the Phenolic Profile of Three Sardinian Pomace Extracts
    Author(s): I Castangia, M Aroffu, F Fulgheri, R Abi Rached, F Corrias, G Sarais, …
    Year: 2024

 

  • Title: Innovation in Cannon Puffing Technology for the Homogenization of Bulk Treatment: Half‐Popped Purple Corn, a New Healthy Snack
    Author(s): HN Rajha, E Debs, R Abi Rached, K El Khoury, M Al‐Kazzi, R Mrad, …
    Year: 2021

 

  • Title: Exploring the Efficacy and Industrial Potential of Polyphenol Products from Grapes and Their By-Products
    Author(s): R Abi Rached, M Perra, ML Manca, HN Rajha, N Louka, RG Maroun, …
    Year: 2024

 

  • Title: A Preliminary Investigation on Hydrogel Disks Imbibed with Enriched Transfersomes as a Promising Tool to Promote the Cutaneous Deposition of Vaccine Antigens
    Author(s): M Aroffu, R Abi Rached, I Castangia, P Italiani, L D’Apice, …
    Year: 2024

 

  • Title: Preliminary Evaluation of the In Vitro and In Vivo Efficacy of a Novel Nanovesicle-Doped Nanoemulsion Co-Loading Artemisinin and Quercetin as a Promising Strategy to Improve …
    Author(s): F Fulgheri, M Ramírez, L Román-Álamo, P Gasco, M Manconi, M Aroffu, …
    Year: 2025

 

  • Title: Clinical Trial to Evaluate the Effect of Grape Seed Extract-Loaded Hyalurosomes on Skin Wellness
    Author(s): RA Rached, M Habre, Y Salem, J Khodeir, M Allaw, I Castangia, …
    Year: 2025

 

🔗 Conclusion 🔗

With an unwavering passion for science and an unrelenting drive for discovery, Rita Joseph Abi Rached stands as a beacon of innovation, inspiring future generations to embrace sustainability, research, and the transformative power of science. Her legacy in food science and biochemistry will continue to shape the future of sustainable research, leaving a lasting impact on both academia and industry.

Daša Zupančič | Cellular Neuroscience | Best Researcher Award

Published on by Neuroscientists

Assoc. Prof. Dr. Daša Zupančič | Cellular Neuroscience | Best Researcher Award

Assoc. Prof. Dr. Daša Zupančič, Faculty of Medicine, University of Ljubljana, Slovenia.

Daša Zupančič is a distinguished academic and researcher specializing in cell biology, urothelial pathology, and medical education. Her extensive contributions to scientific research, particularly in the field of urothelial repair and cancer transformation, have earned her recognition, including the EMBO award. She has played a crucial role in mentoring and teaching, guiding future generations of researchers and medical professionals.

Profile

Orcid

✨ Early Academic Pursuits ✨

Daša Zupančič embarked on her academic journey with an unwavering passion for cell biology and medicine. She earned her Master’s degree in 2002 from the University of Ljubljana, Faculty of Medicine, where she meticulously explored cellular and molecular biological changes in the rat bladder urothelium following cyclophosphamide exposure. This formative research laid the foundation for her Ph.D., which she successfully completed in 2006, investigating the protective role of melatonin in urothelial injury and repair. Her dedication to advancing biomedical knowledge was evident from the very beginning of her scholarly career.

🎓 Professional Endeavors 🎓

Since 2006, Daša Zupančič has been an esteemed Associate Professor at the University of Ljubljana, Faculty of Medicine, Institute of Cell Biology. Prior to this, she gained valuable experience as a Young Researcher and Teaching Assistant from 1999 to 2006. Her extensive expertise and commitment to education have made her an integral part of the institution, where she continuously fosters scientific curiosity and excellence among students and colleagues alike.

🎡 Contributions and Research Focus 🎡

Throughout her career, Daša Zupančič has dedicated her research to understanding cellular mechanisms in urothelial biology and pathology. Her investigations into cyclophosphamide-induced urothelial injury, melatonin’s protective effects, and retinoid signaling pathways in urothelial cancer transformation have provided valuable insights into cellular repair processes. Her work extends beyond laboratory research, influencing the medical community’s approach to urothelial diseases and potential therapeutic advancements.

🏆 Accolades and Recognition 🏆

Her exceptional contributions to biomedical research have been recognized on multiple platforms. In 2017, she was honored with the prestigious EMBO award for her short-term scholarship project on the role of the retinoid signaling pathway in urothelial cancer transformation. This recognition underscores her significant impact on the scientific community and highlights her pioneering approach to understanding cancer pathophysiology.

👨‍🎓 Impact and Influence 👨‍🎓

A dedicated mentor, Daša Zupančič has guided numerous students towards academic excellence. Between 2014 and 2025, she has successfully mentored four master’s students and is currently supervising two more. In addition, she has overseen the research endeavors of four Ph.D. candidates, with one having successfully defended their dissertation in 2023 and another expected to graduate in 2025. Her mentorship has shaped the next generation of biomedical researchers, fostering a culture of rigorous inquiry and scientific discovery.

📚 Legacy and Future Contributions 📚

Beyond her research, Daša Zupančič plays a pivotal role in academia through her extensive teaching engagements. Since 2000, she has been a cornerstone of education at the University of Ljubljana, contributing to multiple faculties, including Medicine, Biotechnical Sciences, Health Sciences, and Pharmacy. She teaches a range of graduate and doctoral courses, covering essential subjects such as Medical Cell Biology, Immunology, and Research in Medicine. Her dedication to education ensures that her knowledge and expertise continue to shape the minds of aspiring medical professionals and researchers for years to come.

Publication

  • Vitamin A‐Enriched Diet Increases Urothelial Cell Proliferation by Upregulating Itga3 and Areg After Cyclophosphamide‐Induced Injury in Mice
    Authors: Brina Dragar, Simona Kranjc Brezar, Maja Čemažar, Tanja Jesenko, Rok Romih, Mateja Erdani Kreft, Tadeja Kuret, Daša Zupančič
    Year: 2025

 

  • Selective Targeting of Lectins and Their Macropinocytosis in Urothelial Tumours: Translation from in vitro to ex vivo
    Authors: Nataša Resnik, Tanja Višnjar, Tomaž Smrkolj, Mateja Erdani Kreft, Rok Romih, Daša Zupančič
    Year: 2023

 

  • Nanodiamonds as Possible Tools for Improved Management of Bladder Cancer and Bacterial Cystitis
    Authors: Daša Zupančič, Peter Veranič
    Year: 2022

 

  • Transmission Electron Microscopy Demonstration of Reduced Endothelial Glycocalyx in Severe Preeclampsia
    Authors: Mugerli S, Zupančič D, Rok Romih, Lučovnik M
    Year: 2022

 

  • Vitamin A and Retinoids in Bladder Cancer Chemoprevention and Treatment: A Narrative Review of Current Evidence, Challenges and Future Prospects
    Authors: Larisa Tratnjek, Jera Jeruc, Rok Romih, Daša Zupančič
    Year: 2021

 

  • Immunohistochemistry as a Paramount Tool in Research of Normal Urothelium, Bladder Cancer and Bladder Pain Syndrome
    Authors: Daša Zupančič, Rok Romih
    Year: 2021

 

  • Combined Lectin- and Immuno-Histochemistry (CLIH) for Applications in Cell Biology and Cancer Diagnosis: Analysis of Human Urothelial Carcinomas
    Authors: Daša Zupančič
    Year: 2020

 

  • Vitamin A Rich Diet Diminishes Early Urothelial Carcinogenesis by Altering Retinoic Acid Signaling
    Authors: Daša Zupančič, Jelena Korać-Prlić, Mateja Erdani Kreft, Lucija Franković, Katarina Vilović, Jera Jeruc, Rok Romih, Janoš Terzić
    Year: 2020

 

  • Lectins as Possible Tools for Improved Urinary Bladder Cancer Management
    Authors: Daša Zupančič
    Year: 2019

 

  • Co-Culturing Porcine Normal Urothelial Cells, Urinary Bladder Fibroblasts and Smooth Muscle Cells for Tissue Engineering Research
    Authors: Daša Zupančič
    Year: 2018

 

🌟 Conclusion 🌟

With a career dedicated to pioneering research, impactful mentorship, and transformative education, Daša Zupančič continues to leave a lasting legacy in the scientific and academic communities. Her work not only enhances understanding of urothelial biology but also inspires innovation and discovery among young scientists. As she continues her academic and research endeavors, her influence on the field will undoubtedly grow, shaping the future of biomedical sciences.

 

Jeffrey Holt | Hearing and Sensory Transduction | Lifetime achievement Award

Published on by Neuroscientists

Prof. Jeffrey Holt | Hearing and Sensory Transduction | Lifetime achievement Award

Prof. Jeffrey Holt,  Harvard Medical School / Boston Children’s Hospital, United States.

Dr. Jeffrey R. Holt is a distinguished scientist whose groundbreaking contributions to auditory neuroscience and inner ear physiology have significantly advanced the field of otolaryngology. Currently serving as a Professor of Otolaryngology and Neurology at Boston Children’s Hospital and Harvard Medical School, Dr. Holt’s career is marked by an unwavering commitment to understanding the molecular and physiological mechanisms underlying hearing and balance disorders.

Profile

Google Scholar

 

Early Academic Pursuits 🎓

Born in Buffalo, NY, Dr. Holt’s passion for science was evident early in his academic journey. He earned his Bachelor of Science degree in Biology from Wofford College in 1986, laying a strong foundation in the life sciences. His quest for knowledge led him to the University of Rochester, where he pursued a Master’s degree in Physiology in 1992, followed by a Ph.D. in Physiology in 1995. His doctoral research provided deep insights into the intricate workings of sensory physiology, setting the stage for his future research endeavors in auditory neuroscience.

Professional Endeavors and Leadership 👩‍💼

Following his Ph.D., Dr. Holt embarked on postdoctoral training at Harvard Medical School, Massachusetts General Hospital, and the Howard Hughes Medical Institute. His extensive training in neurobiology enabled him to transition into academic roles, beginning as an Instructor in Neurobiology at Harvard Medical School and Massachusetts General Hospital from 1999 to 2001. He later joined the University of Virginia as an Assistant Professor of Neuroscience, where he progressed to Associate Professor before returning to Harvard in 2011. Since 2016, he has held the esteemed position of Professor of Otolaryngology at Boston Children’s Hospital and Harvard Medical School, as well as a faculty affiliation with the Harvard-MIT Health Sciences and Technology (HST) program.

Contributions and Research Focus 🌍

Dr. Holt’s pioneering research has been instrumental in decoding the molecular basis of hearing and balance disorders. His work focuses on sensory hair cells of the inner ear, aiming to uncover the genetic and physiological mechanisms that contribute to hearing loss. His studies have explored ion channel function, hair cell mechanotransduction, and gene therapy approaches for hereditary deafness. His innovative research has opened new avenues for therapeutic interventions, including the development of gene therapies targeting Usher syndrome and other genetic hearing disorders.

Accolades and Recognition 🏆

Throughout his career, Dr. Holt has been widely recognized for his contributions to auditory science. He has played key leadership roles in prestigious scientific organizations, serving as Chair of the Usher Syndrome Society Scientific Advisory Committee and Co-Chair of major international conferences such as the Keystone Conference on Sensory Systems and the New York Academy of Sciences Meeting. His service on various NIH and NIDCD advisory committees reflects his influence in shaping national research priorities in hearing and balance disorders.

Impact and Influence on Scientific Community 🌐

Dr. Holt’s impact extends beyond research, as he has been a dedicated mentor and educator throughout his career. He has guided numerous graduate students and postdoctoral fellows, serving on thesis and qualifying exam committees at Harvard Medical School. As a course director and research mentor, he has played a crucial role in training the next generation of auditory neuroscientists. His leadership in academic and scientific communities has helped bridge the gap between fundamental research and clinical applications in hearing restoration.

Legacy and Future Contributions 💪

With a legacy rooted in groundbreaking discoveries and scientific leadership, Dr. Holt continues to push the boundaries of auditory neuroscience. His ongoing research in gene therapy for hereditary deafness holds the promise of transforming lives through novel treatments for hearing loss. As a visionary in the field, his work is set to inspire future advancements in otolaryngology, offering hope to millions affected by hearing and balance disorders worldwide. His dedication to research, education, and clinical impact ensures that his contributions will leave a lasting imprint on auditory science for generations to come.

 

Publication

  • TRPA1 is a candidate for the mechanosensitive transduction channel of vertebrate hair cells
    Authors: DP Corey, J García-Añoveros, JR Holt, KY Kwan, SY Lin, MA Vollrath, …
    Year: 2004

 

  • Treatment of autosomal dominant hearing loss by in vivo delivery of genome editing agents
    Authors: X Gao, Y Tao, V Lamas, M Huang, WH Yeh, B Pan, YJ Hu, JH Hu, …
    Year: 2018

 

  • Mechanotransduction in mouse inner ear hair cells requires transmembrane channel–like genes
    Authors: Y Kawashima, GSG Géléoc, K Kurima, V Labay, A Lelli, Y Asai, …
    Year: 2011

 

  • TMC1 and TMC2 are components of the mechanotransduction channel in hair cells of the mammalian inner ear
    Authors: B Pan, GS Géléoc, Y Asai, GC Horwitz, K Kurima, K Ishikawa, …
    Year: 2013

 

  • Continuous evolution of base editors with expanded target compatibility and improved activity
    Authors: BW Thuronyi, LW Koblan, JM Levy, WH Yeh, C Zheng, GA Newby, …
    Year: 2019

 

  • Differential distribution of stem cells in the auditory and vestibular organs of the inner ear
    Authors: K Oshima, CM Grimm, CE Corrales, P Senn, R Martinez Monedero, …
    Year: 2007

 

  • A chemical-genetic strategy implicates myosin-1c in adaptation by hair cells
    Authors: JR Holt, SKH Gillespie, DW Provance, K Shah, KM Shokat, DP Corey, …
    Year: 2002

 

  • A synthetic AAV vector enables safe and efficient gene transfer to the mammalian inner ear
    Authors: LD Landegger, B Pan, C Askew, SJ Wassmer, SD Gluck, A Galvin, …
    Year: 2017

 

  • Calcium imaging of single stereocilia in hair cells: localization of transduction channels at both ends of tip links
    Authors: W Denk, JR Holt, GMG Shepherd, DP Corey
    Year: 1995

 

  • TMC1 forms the pore of mechanosensory transduction channels in vertebrate inner ear hair cells
    Authors: B Pan, N Akyuz, XP Liu, Y Asai, C Nist-Lund, K Kurima, BH Derfler, …
    Year: 2018

 

Conclusion 🎯

Dr. Holt’s contributions to auditory neuroscience have revolutionized the field, bridging fundamental research with clinical applications. His groundbreaking work in gene therapy holds immense potential for treating hereditary hearing disorders, making a profound impact on global healthcare. As a researcher, educator, and leader, his legacy will continue to inspire innovation in otolaryngology and improve the lives of individuals affected by hearing and balance impairments for generations to come.

 

Pongrama Ramasoota | Molecular and Cellular Neuroscience | Best Researcher Award

Published on by Neuroscientists

Prof. Dr. Pongrama Ramasoota | Molecular and Cellular Neuroscience | Best Researcher Award

Prof. Dr. Pongrama Ramasoota, Mahidol University, Thailand.

Dr. Pongrama Ramasoota is a distinguished professor and researcher specializing in antibody research and virology at the Centre of Excellence for Antibody Research (CEAR), Mahidol University, Thailand. With a strong academic foundation in veterinary medicine, public health, and microbiology, he has dedicated his career to developing therapeutic and diagnostic monoclonal antibodies against viruses such as Dengue, Rabies, Foot and Mouth Disease, and Influenza. His contributions extend beyond infectious disease research, as he has also explored anti-aging supplements for humans and pets. Recognized with numerous national and international awards, his research has significantly impacted medical biotechnology, earning him a reputation as a leading scientist in his field.

 

Profile

Scopus

 

🎓 Early Academic Pursuits

Pongrama Ramasoota’s journey into the world of microbiology and antibody research began with a solid foundation in veterinary medicine. He earned his Doctor of Veterinary Medicine from Kasetsart University, where his fascination with infectious diseases and immunology took root. His academic pursuits led him to Mahidol University, where he obtained a Master of Public Health, further broadening his expertise in disease prevention and control. Driven by a passion for scientific exploration, he pursued a Master of Science and Ph.D. in Microbiology at the prestigious Swedish University of Agricultural Sciences in Uppsala, Sweden. These formative years were instrumental in shaping his career as a leading researcher in antibody development and disease management.

🏥 Professional Endeavors

As a distinguished professor at the Centre of Excellence for Antibody Research (CEAR) within the Faculty of Tropical Medicine, Mahidol University, Dr. Ramasoota has dedicated his career to advancing the field of immunotherapy. His research primarily focuses on developing neutralizing monoclonal antibodies to combat viral threats such as Dengue and Rabies. Over the years, he has led groundbreaking projects aimed at creating effective therapeutic and diagnostic solutions. His expertise has also extended beyond academia, as he collaborates with industry leaders to translate research into practical applications that benefit global health.

🦠 Contributions and Research Focus

Dr. Ramasoota’s contributions to medical research are vast and impactful. His work on neutralizing human monoclonal antibodies against Dengue and Rabies viruses has paved the way for potential life-saving treatments. His research extends to diagnostic monoclonal antibodies for detecting Foot and Mouth Disease Virus (FMDV) and Influenza, significantly enhancing disease surveillance. Beyond infectious diseases, he has also ventured into anti-aging research, developing natural supplements to promote longevity in both humans and pets. His relentless pursuit of innovation continues to drive advancements in virology, immunotherapy, and biotechnology.

🏆 Accolades and Recognition

Dr. Ramasoota’s contributions to science have been recognized with numerous prestigious awards. He was honored as Thailand’s Outstanding Researcher in 2020 and named Thailand’s Outstanding Veterinarian in 2016. His innovative work earned him multiple Outstanding Research and Invention Awards from the National Research Council of Thailand between 2008 and 2016. He has also received international recognition, including a gold medal from the 2014 Taipei Invention & Techno Mart and awards from the Korea Invention Association and the International Federation of Inventors’ Associations. These accolades underscore his influence as a pioneer in antibody research and biotechnology.

🌍 Impact and Influence

With an H-index of 18 and over 1,038 citations on Scopus, Dr. Ramasoota’s research has significantly influenced the scientific community. His findings have been instrumental in shaping new treatment strategies for viral diseases, providing hope for better therapeutic interventions. Collaborating with industry leaders such as Advy Chemical (India) and Thai-Naoka (Thailand), he has helped bridge the gap between research and real-world applications. His contributions to diagnostic tools and monoclonal antibody therapies continue to shape the future of virology and medical biotechnology.

📚 Legacy and Future Contributions

Beyond his research endeavors, Dr. Ramasoota has authored books that highlight his expertise in environmental management and anti-aging technologies. His book Hallmarks of Aging, Technology and Innovation for Anti-Aging explores groundbreaking advancements in longevity research, demonstrating his commitment to improving human health across various dimensions. As he continues to innovate, his legacy as a leading researcher in antibody development and viral immunotherapy will inspire future generations of scientists. His ongoing efforts to combat infectious diseases and promote healthier aging promise a lasting impact on global health and biotechnology.

Publication

  1. Title: Development of novel canine phage display-derived neutralizing monoclonal antibody fragments against rabies virus from immunized dogs
    Authors: A. Chorpunkul, U. Boonyuen, K. Limkittikul, P. Lekcharoensuk, P. Ramasoota
    Year: 2024

 

  1. Title: Characterization of Vibrio parahaemolyticus isolated from clinical specimens and oysters in Thailand
    Authors: N. Tewawong, S. Kowaboot, S. Kengkarn, P. Ramasoota, O. Suthienkul
    Year: 2024

 

  1. Title: Nicotiana benthamiana as a potential source for producing anti-dengue virus D54 neutralizing therapeutic antibody
    Authors: S. Krittanai, K. Rattanapisit, C.J.I. Bulaon, R. Strasser, W. Phoolcharoen
    Year: 2024

 

  1. Title: Associations of effort-reward imbalance at work and quality of life among workers after stroke: a one-year longitudinal study in Thailand
    Authors: S. Naknoi, J. Li, P. Ramasoota, N. Soonthornworasiri, O. Kaewboonchoo
    Year: 2023

 

  1. Title: Potential Protective Effect of Dengue NS1 Human Monoclonal Antibodies against Dengue and Zika Virus Infections
    Authors: R. Sootichote, W. Puangmanee, S. Benjathummarak, P. Ramasoota, P. Pitaksajjakul
    Year: 2023

 

  1. Title: A replication competent luciferase-secreting DENV2 reporter for sero-epidemiological surveillance of neutralizing and enhancing antibodies
    Authors: K. Saipin, B.K. Thaisomboonsuk, B. Siridechadilok, N. Sittisombut, J. Junjhon
    Year: 2022

 

  1. Title: Spread of a Novel Indian Ocean Lineage Carrying E1‐K211E/E2‐V264A of Chikungunya Virus East/Central/South African Genotype across the Indian Subcontinent, Southeast Asia, and Eastern Africa
    Authors: J. Phadungsombat, H.A. Imad, E.E. Nakayama, W. Piyaphanee, T. Shioda
    Year: 2022

 

🎯 Conclusion

Dr. Ramasoota’s work has not only advanced scientific knowledge but also contributed to real-world solutions in disease treatment and diagnostics. His collaborations with industries and commitment to innovation ensure that his research continues to benefit global health. As he continues to push the boundaries of antibody research and anti-aging science, his legacy will inspire future generations of scientists, leaving a lasting impact on virology, immunotherapy, and biotechnology.